On Friday, Immunome Inc (NASDAQ: IMNM) opened higher 14.13% from the last session, before settling in for the closing price of $10.15. Price fluctuations for IMNM have ranged from $5.15 to $15.20 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -38.15% annually for the last half of the decade. Company’s average yearly earnings per share was noted 57.83% at the time writing. With a float of $79.76 million, this company’s outstanding shares have now reached $87.01 million.
Immunome Inc (IMNM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunome Inc is 8.37%, while institutional ownership is 85.13%. The most recent insider transaction that took place on Jun 03 ’25, was worth 46,900. In this transaction Director of this company bought 5,000 shares at a rate of $9.38, taking the stock ownership to the 36,415 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Director bought 7,800 for $7.78, making the entire transaction worth $60,684. This insider now owns 31,415 shares in total.
Immunome Inc (IMNM) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.78 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.58) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.66% during the next five years compared to -38.15% drop over the previous five years of trading.
Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators
Check out the current performance indicators for Immunome Inc (IMNM). In the past quarter, the stock posted a quick ratio of 12.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 80.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.09, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -2.32 in one year’s time.
Technical Analysis of Immunome Inc (IMNM)
Let’s dig in a bit further. During the last 5-days, its volume was 2.77 million. That was better than the volume of 1.08 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 60.94%.
During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 86.21%, which indicates a significant increase from 80.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.88 in the past 14 days, which was higher than the 0.60 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.14, while its 200-day Moving Average is $9.44. However, in the short run, Immunome Inc’s stock first resistance to watch stands at $12.15. Second resistance stands at $12.70. The third major resistance level sits at $13.75. If the price goes on to break the first support level at $10.55, it is likely to go to the next support level at $9.50. The third support level lies at $8.95 if the price breaches the second support level.
Immunome Inc (NASDAQ: IMNM) Key Stats
There are currently 87,045K shares outstanding in the company with a market cap of 1.01 billion. Presently, the company’s annual sales total 9,040 K according to its annual income of -292,960 K. Last quarter, the company’s sales amounted to 4,020 K and its income totaled -43,400 K.
